HomeECX • FRA
add
Epigenomics AG
Previous close
€0.92
Day range
€0.92 - €0.93
Year range
€0.50 - €1.59
Market cap
815.59K EUR
Avg Volume
246.00
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 10.00K | — |
Operating expense | 87.50K | -68.86% |
Net income | -55.00K | 95.70% |
Net profit margin | -550.00 | — |
Earnings per share | — | — |
EBITDA | -74.50K | 73.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 414.00K | -55.34% |
Total assets | 11.62M | -2.00% |
Total liabilities | 11.61M | -2.02% |
Total equity | 2.00K | — |
Shares outstanding | 876.98K | — |
Price to book | ∞ | — |
Return on assets | -1.67% | — |
Return on capital | -1.70% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -55.00K | 95.70% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Headquarters
Website
Employees
3
